Oral to iv keppra conversion

Rapid intravenous administration of DILANTIN increases the risk of adverse cardiovascular reactions, including severe hypotension and cardiac arrhythmias. Cardiac arrhythmias have included bradycardia , heart block, ventricular tachycardia , and ventricular fibrillation which have resulted in asystole , cardiac arrest, and death. Severe complications are most commonly encountered in critically ill patients, elderly patients, and patients with hypotension and severe myocardial insufficiency. However, cardiac events have also been reported in adults and children without underlying cardiac disease or comorbidities and at recommended doses and infusion rates.

It isn’t followed to fix the remedy under the application of soporific medicamental agents, organic sicknesses of brain and intellectual illnesses in heavy stages. There are some collateral advantages such as

  • from the nervous system – vertigoes, headaches, attention lowering, slowdown of psychical and motive reactions, ataxy, disorientation, mood depression and drowsiness;
  • from the circulatory system – neutropenia, shivering, anemia, hyperthermia;
  • from the digestive system – heightened salivation, nausea, heartburn, damages of liver’s operation, diarrhea.
Under the protracted application of this medicament it may appearance different allergic reactions (nettle rush, itching, redness and burning). Sometimes it may start the assaults of aggression, hallucinations, tremor, leucocytopenia, insomnia and suicidal tendency.

Oral to iv keppra conversion

oral to iv keppra conversion


oral to iv keppra conversionoral to iv keppra conversionoral to iv keppra conversionoral to iv keppra conversionoral to iv keppra conversion